Providence Medical Foundation
Providence Medical Foundation was paid $52.59M by Medicaid between Jan 2018 and Dec 2024, across 331 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 14% of everything it billed.
BREA, CA 92821
Next to other Radiology Clinic/Center providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 112,651 | $4.35M | |
| 2019 | 177,882 | $6.14M | |
| 2020 | 173,958 | $6.09M | |
| 2021 | 211,440 | $7.12M | |
| 2022 | 266,550 | $8.41M | |
| 2023 | 352,416 | $9.86M | |
| 2024incomplete | 351,117 | $10.62M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 249,770 | 236,807 | $7.23M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.2% | 242,541 | 230,384 | $4.85M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.9% | 38,251 | 37,613 | $3.12M |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 5.5% | 31,731 | 21,070 | $2.90M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 5.4% | 24,718 | 11,462 | $2.84M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 5.3% | 81,866 | 32,685 | $2.76M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 5.0% | 62,153 | 26,018 | $2.62M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 4.7% | 31,365 | 30,828 | $2.46M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.9% | 28,068 | 27,927 | $1.54M |
| S9083 | Global fee urgent care centers | 2.9% | 27,856 | 25,047 | $1.50M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.7% | 26,717 | 26,194 | $1.41M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.4% | 15,720 | 15,567 | $1.24M |
319 more codes
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2.3% | 92,188 | $1.19M |
| 96156 | 2.0% | 12,770 | $1.07M | |
| 99215 | Doctor's office visit, returning patient (complex) | 2.0% | 19,261 | $1.05M |
| 99223 | Prolong inpt eval add15 m | 1.9% | 14,584 | $1.02M |
| 59425 | 1.6% | 10,301 | $852K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.2% | 16,673 | $606K |
| 99222 | Initial hospital care, per day, moderate complexity | 1.1% | 9,233 | $600K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1.1% | 802 | $556K |
| 95144 | <1% | 703 | $523K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 11,169 | $453K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 10,417 | $422K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 9,565 | $404K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,541 | $395K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,841 | $388K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 11,514 | $371K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 7,418 | $369K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 16,184 | $361K |
| 99205 | Prolong outpt/office vis | <1% | 3,317 | $348K |
| 99285 | Emergency room visit (most serious) | <1% | 2,441 | $277K |
| 93000 | <1% | 11,344 | $273K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,217 | $258K |
| Z1034 | <1% | 4,747 | $258K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 1,865 | $238K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 398 | $191K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 1,279 | $180K |
| 95811 | <1% | 746 | $179K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 12,441 | $177K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 5,125 | $165K |
| 99243 | <1% | 1,429 | $155K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,105 | $145K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 194 | $137K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 3,744 | $135K |
| 90686 | <1% | 14,137 | $126K | |
| G9920 | Screening performed and negative | <1% | 9,300 | $122K |
| H1000 | Prenatal care, at-risk assessment | <1% | 695 | $116K |
| 59430 | <1% | 1,274 | $112K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 973 | $107K |
| 92551 | <1% | 8,938 | $101K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 600 | $99K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 277 | $92K |
| 96151 | <1% | 4,086 | $91K | |
| 95117 | <1% | 5,135 | $88K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,314 | $85K |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | <1% | 586 | $84K |
| 99255 | <1% | 823 | $79K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,350 | $76K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 35,563 | $75K |
| 90670 | <1% | 8,293 | $72K | |
| 99245 | <1% | 437 | $70K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 3,234 | $69K |
| 59025 | Fetal non-stress test | <1% | 5,026 | $67K |
| 99254 | <1% | 854 | $60K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 1,084 | $58K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 237 | $58K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 298 | $53K |
| 90723 | <1% | 5,975 | $53K | |
| 77427 | <1% | 678 | $49K | |
| 17110 | <1% | 571 | $47K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 16,851 | $46K |
| 99221 | <1% | 1,785 | $45K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 630 | $42K |
| 90633 | <1% | 5,150 | $42K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,914 | $41K |
| 90651 | <1% | 3,667 | $41K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 508 | $41K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,334 | $41K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 276 | $40K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 389 | $39K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,137 | $38K |
| 76641 | <1% | 276 | $37K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 408 | $37K |
| 90647 | <1% | 4,664 | $37K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 4,435 | $36K |
| 73610 | <1% | 1,561 | $36K | |
| 90837 | Psychotherapy session, about an hour | <1% | 314 | $36K |
| 90715 | <1% | 2,641 | $36K | |
| 73110 | <1% | 1,496 | $34K | |
| 93299 | <1% | 477 | $30K | |
| G9012 | Other specified case management service not elsewhere classified | <1% | 961 | $28K |
| 93298 | <1% | 813 | $25K | |
| 90734 | <1% | 3,185 | $24K | |
| 20553 | <1% | 298 | $24K | |
| 93016 | <1% | 1,067 | $24K | |
| 93297 | <1% | 981 | $23K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 11,141 | $23K |
| 95806 | <1% | 123 | $22K | |
| 90681 | <1% | 2,397 | $22K | |
| 90700 | <1% | 2,443 | $21K | |
| 90707 | <1% | 2,325 | $21K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,957 | $21K |
| 90716 | <1% | 2,313 | $21K | |
| 76642 | <1% | 229 | $21K | |
| 76830 | Ultrasound, transvaginal | <1% | 265 | $21K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 51 | $20K |
| 99000 | <1% | 6,153 | $20K | |
| 97010 | <1% | 1,715 | $20K | |
| 90710 | <1% | 2,397 | $20K | |
| 77066 | Tomosynthesis, mammo | <1% | 119 | $20K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 622 | $20K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 134 | $19K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,155 | $19K |
| 90696 | <1% | 2,104 | $18K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,875 | $17K |
| 96150 | <1% | 736 | $17K | |
| 93018 | <1% | 967 | $17K | |
| 73130 | <1% | 689 | $16K | |
| 29075 | <1% | 128 | $16K | |
| 20610 | <1% | 736 | $16K | |
| 90620 | <1% | 984 | $16K | |
| 99442 | <1% | 4,270 | $16K | |
| 99385 | <1% | 252 | $16K | |
| 59514 | <1% | 35 | $16K | |
| 85018 | <1% | 8,870 | $15K | |
| 73630 | <1% | 700 | $15K | |
| 72100 | <1% | 461 | $14K | |
| 99292 | <1% | 292 | $14K | |
| 99460 | <1% | 205 | $14K | |
| 83655 | <1% | 1,497 | $14K | |
| 99383 | <1% | 317 | $14K | |
| 99492 | <1% | 105 | $14K | |
| 99493 | <1% | 184 | $13K | |
| 76942 | <1% | 332 | $13K | |
| 93015 | <1% | 147 | $13K | |
| 97014 | <1% | 946 | $13K | |
| 81002 | <1% | 18,456 | $13K | |
| 90648 | <1% | 1,330 | $12K | |
| 77336 | <1% | 366 | $12K | |
| 93017 | <1% | 257 | $12K | |
| 73562 | <1% | 476 | $11K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 3,958 | $11K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 56 | $11K |
| 94729 | <1% | 483 | $11K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 82 | $11K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 183 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 723 | $10K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 422 | $10K |
| 99497 | <1% | 94 | $10K | |
| 73030 | <1% | 470 | $10K | |
| 95911 | <1% | 42 | $10K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 297 | $9K |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 763 | $9K |
| 92557 | <1% | 131 | $9K | |
| 92552 | <1% | 805 | $9K | |
| 99152 | <1% | 205 | $9K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 525 | $9K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 397 | $9K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,729 | $9K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 123 | $8K |
| 90680 | <1% | 940 | $8K | |
| 90677 | <1% | 666 | $8K | |
| 94010 | <1% | 214 | $8K | |
| 95909 | <1% | 39 | $8K | |
| 29405 | <1% | 56 | $8K | |
| 99441 | <1% | 1,765 | $8K | |
| 99443 | <1% | 1,261 | $7K | |
| 80061 | Lipid panel | <1% | 646 | $7K |
| 64615 | <1% | 55 | $7K | |
| 94060 | <1% | 317 | $7K | |
| G9008 | Coordinated care fee, physician coordinated care oversight services | <1% | 14,012 | $7K |
| 73564 | <1% | 243 | $7K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 46 | $7K |
| 81025 | <1% | 9,174 | $7K | |
| 64405 | <1% | 82 | $7K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 140 | $6K |
| 96127 | <1% | 2,087 | $6K | |
| 77014 | <1% | 150 | $6K | |
| 77065 | Tomosynthesis, mammo | <1% | 52 | $6K |
| 51798 | <1% | 94 | $6K | |
| 99253 | <1% | 124 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 734 | $6K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,997 | $6K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 113 | $6K |
| 25600 | <1% | 24 | $6K | |
| 93294 | <1% | 347 | $6K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 421 | $6K |
| 97750 | <1% | 158 | $5K | |
| 95115 | <1% | 642 | $5K | |
| 99384 | <1% | 109 | $5K | |
| 77080 | <1% | 180 | $5K | |
| 90656 | <1% | 765 | $5K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 110 | $5K |
| 99382 | <1% | 82 | $5K | |
| 90961 | <1% | 271 | $5K | |
| J0897 | Injection, denosumab, 1 mg | <1% | 15 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,430 | $5K |
| 99242 | <1% | 57 | $5K | |
| 94727 | <1% | 145 | $4K | |
| 84439 | <1% | 570 | $4K | |
| 99381 | <1% | 76 | $4K | |
| 29065 | <1% | 28 | $4K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 5,843 | $4K |
| 92504 | <1% | 163 | $4K | |
| 88141 | <1% | 71 | $4K | |
| 99220 | <1% | 67 | $3K | |
| 69210 | <1% | 130 | $3K | |
| 62323 | <1% | 13 | $3K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 114 | $3K |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 644 | $3K |
| 99306 | Prolong nursin fac eval 15m | <1% | 182 | $3K |
| 99451 | <1% | 80 | $3K | |
| Z1032 | <1% | 24 | $3K | |
| 82962 | <1% | 2,314 | $3K | |
| 94375 | <1% | 63 | $3K | |
| 93245 | <1% | 25 | $3K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,659 | $3K |
| 76770 | <1% | 26 | $3K | |
| 99356 | <1% | 66 | $3K | |
| 77334 | <1% | 32 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 581 | $2K |
| 93248 | <1% | 99 | $2K | |
| 99218 | <1% | 81 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 59 | $2K |
| 73080 | <1% | 87 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,295 | $2K |
| 99386 | <1% | 39 | $2K | |
| 94726 | <1% | 157 | $2K | |
| 93880 | <1% | 13 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,624 | $2K |
| 99406 | <1% | 221 | $2K | |
| 92550 | <1% | 58 | $2K | |
| 90685 | <1% | 196 | $2K | |
| 95251 | <1% | 67 | $2K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 30 | $2K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 26 | $2K |
| 31575 | <1% | 13 | $2K | |
| 76536 | <1% | 27 | $2K | |
| 97035 | <1% | 170 | $1K | |
| 99072 | <1% | 302 | $1K | |
| 93296 | <1% | 180 | $1K | |
| 81003 | <1% | 5,049 | $1K | |
| 99173 | <1% | 1,686 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 165 | $1K |
| 99494 | <1% | 14 | $1K | |
| 93308 | <1% | 33 | $1K | |
| 31231 | <1% | 12 | $1K | |
| 99217 | <1% | 55 | $1K | |
| 99153 | Mod sedat endo service >5yrs | <1% | 30 | $1K |
| 77263 | <1% | 12 | $1K | |
| 93295 | <1% | 28 | $1K | |
| 72040 | <1% | 37 | $992.48 | |
| 95800 | <1% | 26 | $992.00 | |
| 73100 | <1% | 58 | $986.10 | |
| G0008 | Administration of influenza virus vaccine | <1% | 677 | $940.59 |
| 11721 | <1% | 210 | $901.25 | |
| 77300 | <1% | 17 | $879.54 | |
| 95717 | <1% | 13 | $870.78 | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 208 | $865.89 |
| 93280 | <1% | 100 | $842.01 | |
| 90688 | <1% | 136 | $833.83 | |
| 93246 | <1% | 57 | $817.26 | |
| 69209 | <1% | 294 | $707.15 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 45 | $606.67 |
| 0001A | <1% | 15 | $600.00 | |
| 99172 | <1% | 31 | $570.40 | |
| 0002A | <1% | 14 | $560.00 | |
| 90697 | <1% | 12 | $529.17 | |
| 0031A | <1% | 13 | $520.00 | |
| 12001 | <1% | 28 | $516.28 | |
| 81001 | <1% | 195 | $491.72 | |
| 90480 | <1% | 12 | $480.00 | |
| 76937 | <1% | 29 | $476.80 | |
| 90662 | <1% | 285 | $465.75 | |
| 86580 | <1% | 109 | $449.05 | |
| 3074F | <1% | 37,483 | $437.50 | |
| 96402 | <1% | 27 | $417.42 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 702 | $392.60 |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 13 | $377.00 |
| 93356 | <1% | 49 | $362.56 | |
| 83735 | <1% | 62 | $347.60 | |
| 85610 | <1% | 672 | $330.53 | |
| 93290 | <1% | 12 | $305.53 | |
| J3121 | Injection, testosterone enanthate, 1 mg | <1% | 34 | $301.00 |
| 73560 | <1% | 29 | $233.21 | |
| 86308 | <1% | 599 | $169.97 | |
| 73590 | <1% | 17 | $164.94 | |
| 86140 | <1% | 35 | $162.05 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 14 | $139.03 |
| 71045 | Radiologic examination, chest; single view | <1% | 12 | $136.17 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 19 | $135.85 |
| 90713 | <1% | 15 | $135.00 | |
| 73140 | <1% | 12 | $134.16 | |
| 82951 | <1% | 13 | $133.77 | |
| 90619 | <1% | 29 | $126.00 | |
| 90714 | <1% | 13 | $117.56 | |
| 90649 | <1% | 13 | $117.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 15 | $109.05 |
| 1111F | <1% | 111 | $96.84 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 58 | $95.30 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 17 | $90.92 |
| 90694 | <1% | 77 | $75.22 | |
| 85652 | <1% | 25 | $59.64 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 74 | $55.07 |
| 10060 | <1% | 13 | $42.44 | |
| 17000 | <1% | 13 | $33.44 | |
| 93325 | <1% | 13 | $28.28 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 248 | $27.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 12 | $19.80 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 16 | $13.96 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 388 | $11.66 |
| 36416 | <1% | 216 | $8.37 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 225 | $8.09 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 12 | $0.96 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 33 | $0.34 |
| 1036F | 0% | 19,016 | $0.00 | |
| 3079F | 0% | 17,373 | $0.00 | |
| 3080F | 0% | 3,415 | $0.00 | |
| 3075F | 0% | 6,936 | $0.00 | |
| H0049 | Alcohol and/or drug screening | 0% | 3,499 | $0.00 |
| 87276 | 0% | 16 | $0.00 | |
| 3354F | 0% | 71 | $0.00 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | 0% | 118 | $0.00 |
| 1220F | 0% | 91 | $0.00 | |
| 3078F | 0% | 29,853 | $0.00 | |
| 3077F | 0% | 6,144 | $0.00 | |
| 90461 | 0% | 1,764 | $0.00 | |
| 3725F | 0% | 164 | $0.00 | |
| 4004F | 0% | 45 | $0.00 | |
| 96160 | 0% | 27 | $0.00 | |
| 99448 | 0% | 47 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.